HRSA-21-120: Healthy Start Initiative: Eliminating Disparities in Perinatal Health Supplement: Action Plans for Infant Health Equity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants of up to $80,000 to the applicants described in the notice. It expected to make about 30 awards worth $2.5 million in total. Applications closed on June 23, 2021.
From the official notice on Grants.gov, last changed May 20, 2021. Checked November 7, 2026.
- Award ceiling$80,000
- Total funding$2.5 million
- Expected awards30
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | May 20, 2021 |
|---|---|
| Deadline | June 23, 2021 |
| Archived by Grants.gov | August 22, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include all current recipients of the Healthy Start Initiative: Eliminating Disparities in Perinatal Health grant (funded under NOFO HRSA-19-049) (start date of April 1, 2019).
Is this a realistic fit?
- Past Healthy Start Initiative awards averaged $4.2 million; this notice allows up to $80,000 per award.
- No cost sharing or match is required.
What the grant funds
The purpose of the HS program is to improve health outcomes before, during, and after pregnancy, and reduce racial/ethnic differences in rates of infant death and adverse perinatal outcomes.
Who has won Healthy Start Initiative grants before
From fiscal 2021 to 2025, Healthy Start Initiative (93.926) awarded $627 million across 150 grant awards, an average of $4.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| National Institute for Childrens Health Quality Inc | Massachusetts | 1 | $21.0 million |
| Maricopa, County of | Arizona | 2 | $9.1 million |
| Global Communities, Inc. | Maryland | 2 | $8.8 million |
| North Carolina Department of Health & Human Services | North Carolina | 2 | $8.6 million |
| Prisma Health-Midlands | South Carolina | 2 | $8.5 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-21-120 still open?
No. It closed on June 23, 2021.
Who can apply for Healthy Start Initiative: Eliminating Disparities in Perinatal Health Supplement: Action Plans for Infant Health Equity?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Healthy Start Initiative: Eliminating Disparities in Perinatal Health Supplement: Action Plans for Infant Health Equity?
Closed June 23, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $80,000 each. About $2.5 million in total across about 30 awards.
Who has won Healthy Start Initiative grants before?
The largest recipients over five fiscal years were National Institute for Childrens Health Quality Inc, Maricopa, County of, Global Communities, Inc. The program made 150 awards worth $627 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)